Literature DB >> 20590484

Outcomes of comprehensive heart care programs in high-risk women.

Amparo C Villablanca1, Laurel A Beckett, Yueju Li, Shantelle Leatherwood, Santosh K Gill, Elsa-Grace V Giardina, Anne L Taylor, Carol Barron, JoAnne M Foody, Suzanne Haynes, Gail D'Onofrio.   

Abstract

OBJECTIVE: The purpose of this study was to improve the fund of knowledge, reduce cardiovascular disease (CVD) risk, and attain Healthy People 2010 objectives among women in model women's heart programs.
METHODS: A 6-month pre/post-longitudinal educational intervention of high-risk women (n = 1310) patients at six U.S. women's heart programs consisted of comprehensive heart health counseling and use of American Heart Association/American College of Cardiology (AHA/ACC) Evidence-Based Guidelines as enhancement to usual care delivered via five integrated components: education/awareness, screening/risk assessment, diagnostic testing/treatment, lifestyle modification/rehabilitation, and tracking/evaluation. Demographics, before and after knowledge surveys, clinical diagnoses, laboratory parameters, and Framingham risk scores were also determined. Changes in fund of knowledge, awareness, and risk reduction outcomes and Healthy People 2010 objectives were determined.
RESULTS: At 6 months, there were statistically significant improvements in fund of knowledge, risk awareness, and clinical outcomes. Participants attained or exceeded >90% of the Healthy People 2010 objectives. Proportions of participants showing increased knowledge and awareness of CVD as the leading killer of women, of all signs and symptoms of a heart attack, and calling 911 increased significantly (11.1%, 25.4%, and 34.6%, respectively). Health behavior counseling for physical activity, diet, and diabetes as CVD risk factors increased significantly (28.3%, 28.2%, and 12.5%, respectively). There was a statistical 4.1% increase in participants with systolic blood pressure (SBP) <140/90 mm Hg, a 4.7% decrease in participants with total cholesterol (TC) >240 mg/dL, a 4.5% decrease in participants with TC >200 mg/dL, a 5.9% decrease in participants with high-density lipoprotein cholesterol (HDL-C) <50 mg/dL, a 4.4% decrease in participants with HDL-C <40 mg/dL, and an 8.8% increase in diabetics with low-density lipoprotein cholesterol (LDL-C) <100 mg/dL.
CONCLUSIONS: CVD prevention built around a comprehensive heart care model program and AHA/ACC Evidence-Based Guidelines can be successful in improving knowledge and awareness, CVD risk factor reduction, and attainment of Healthy People 2010 objectives in high-risk women. Thus, these programs could have a dramatic and lasting impact on the health of women.

Entities:  

Mesh:

Year:  2010        PMID: 20590484      PMCID: PMC2940459          DOI: 10.1089/jwh.2009.1426

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  23 in total

1.  Evidence-based guidelines for cardiovascular disease prevention in women.

Authors:  Lori Mosca; Lawrence J Appel; Emelia J Benjamin; Kathy Berra; Nisha Chandra-Strobos; Rosalind P Fabunmi; Deborah Grady; Constance K Haan; Sharonne N Hayes; Debra R Judelson; Nora L Keenan; Patrick McBride; Suzanne Oparil; Pamela Ouyang; Mehmet C Oz; Michael E Mendelsohn; Richard C Pasternak; Vivian W Pinn; Rose Marie Robertson; Karin Schenck-Gustafsson; Cathy A Sila; Sidney C Smith; George Sopko; Anne L Taylor; Brian W Walsh; Nanette K Wenger; Christine L Williams
Journal:  Circulation       Date:  2004-02-04       Impact factor: 29.690

Review 2.  Results of systematic review of research on diagnosis and treatment of coronary heart disease in women.

Authors:  D Grady; L Chaput; M Kristof
Journal:  Evid Rep Technol Assess (Summ)       Date:  2003-05

3.  Factor retention in EFA: strategies for health behavior researchers.

Authors:  Michael L Stellefson; Bruce W Hanik; Beth H Chaney; J Don Chaney
Journal:  Am J Health Behav       Date:  2009 Sep-Oct

Review 4.  Obesity: assessment and management in primary care.

Authors:  J M Lyznicki; D C Young; J A Riggs; R M Davis
Journal:  Am Fam Physician       Date:  2001-06-01       Impact factor: 3.292

5.  Weight reduction and pharmacologic treatment in obese hypertensives.

Authors:  K Masuo; H Mikami; T Ogihara; M L Tuck
Journal:  Am J Hypertens       Date:  2001-06       Impact factor: 2.689

6.  Measurement characteristics of 2 different self-monitoring tools used in a dietary intervention study.

Authors:  L F Tinker; R E Patterson; A R Kristal; D J Bowen; A Kuniyuki; H Henry; A Shattuck
Journal:  J Am Diet Assoc       Date:  2001-09

7.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

8.  Knowledge of heart attack symptoms in 20 US communities. Results from the Rapid Early Action for Coronary Treatment Community Trial.

Authors:  David C Goff; Paul Mitchell; John Finnegan; Dilip Pandey; Vera Bittner; Henry Feldman; Hendrika Meischke; Robert J Goldberg; Russell V Luepker; James M Raczynski; Lawton Cooper; Clay Mann
Journal:  Prev Med       Date:  2004-01       Impact factor: 4.018

Review 9.  Do you know them when you see them? Women's prodromal and acute symptoms of myocardial infarction.

Authors:  J C McSweeney; M Cody; P B Crane
Journal:  J Cardiovasc Nurs       Date:  2001-04       Impact factor: 2.083

10.  Tracking women's awareness of heart disease: an American Heart Association national study.

Authors:  Lori Mosca; Anjanette Ferris; Rosalind Fabunmi; Rose Marie Robertson
Journal:  Circulation       Date:  2004-02-04       Impact factor: 29.690

View more
  8 in total

1.  The DHHS Office on Women's Health Initiative to Improve Women's Heart Health: focus on knowledge and awareness among women with cardiometabolic risk factors.

Authors:  Elsa-Grace V Giardina; Robert R Sciacca; JoAnne M Foody; Gail D'Onofrio; Amparo C Villablanca; Shantelle Leatherwood; Anne L Taylor; Suzanne G Haynes
Journal:  J Womens Health (Larchmt)       Date:  2011-04-14       Impact factor: 2.681

2.  Advances in Cardiovascular Health in Women over the Past Decade: Guideline Recommendations for Practice.

Authors:  Pejman Raeisi-Giglou; Annabelle Santos Volgman; Hena Patel; Susan Campbell; Amparo Villablanca; Eileen Hsich
Journal:  J Womens Health (Larchmt)       Date:  2017-07-17       Impact factor: 2.681

3.  Outcomes of a Clinic-Based Educational Intervention for Cardiovascular Disease Prevention by Race, Ethnicity, and Urban/Rural Status.

Authors:  Amparo C Villablanca; Christina Slee; Liana Lianov; Daniel Tancredi
Journal:  J Womens Health (Larchmt)       Date:  2016-06-29       Impact factor: 2.681

4.  Promoting heart health in rural women.

Authors:  Pamela Stewart Fahs; Margaret Pribulick; Ishan Canty Williams; Gary D James; Virginia Rovnyak; Virginia Rovynak; Susan M Seibold-Simpson
Journal:  J Rural Health       Date:  2012-10-25       Impact factor: 4.333

5.  The Wahine Heart Wellness Program: A Community Approach to Reducing Women's Cardiovascular Disease Risk.

Authors:  Sandra J Bourgette-Henry; Alice Davis; Jeanie Flood; So Yung Choi; Alika Bourgette
Journal:  Hawaii J Health Soc Welf       Date:  2019-11

6.  Community-based cardiovascular disease prevention to reduce cardiometabolic risk in Latina women: a pilot program.

Authors:  Robin Altman; Jessica Nunez de Ybarra; Amparo C Villablanca
Journal:  J Womens Health (Larchmt)       Date:  2014-02-19       Impact factor: 2.681

7.  Awareness of Cardiovascular Disease and Preventive Behaviors Among Overweight Immigrant Latinas.

Authors:  Deborah Koniak-Griffin; Mary-Lynn Brecht
Journal:  J Cardiovasc Nurs       Date:  2015 Sep-Oct       Impact factor: 2.083

8.  A comprehensive cardiovascular disease lifestyle treatment controlled trial among high-risk African Americans.

Authors:  Sharon K Davis; Rakale Quarells; Gary H Gibbons
Journal:  Open J Prev Med       Date:  2013-12-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.